Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inpegsomatropin Injection in Idiopathic Short Stature (Extension Study)
NCT07894341Phase 3Recruiting
- Sponsor
- Xiamen Tebao Biological Engineering Co., Ltd.
- Start
- Sep 2026
- Primary completion
- Aug 2041
- Countries
- 1
01
Overview
A Phase 3 trial of genotropin miniquick in Idiopathic Short Stature (ISS), sponsored by Xiamen Tebao Biological Engineering Co., Ltd.. Started Sep 2026; status: recruiting.
02
Drugs
genotropin miniquick
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on NCT07894341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07894341.